MAI Wealth Advisors »

Ligand Pharmaceuticals In shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $975k 5.2k 189.07
2025-06-30 $1.4k 12 113.75

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Call Call Option (Principal) (GOOGL)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
State Street Corporation
Chicago Capital
Invesco
Massachusetts Financial Services
Stephens Investment Management Group
Franklin Resources
Geode Capital Management
Congress Asset Management
FMR
Dimensional Fund Advisors
Goldman Sachs Group
Loomis, Sayles and

View all funds holding Ligand Pharmaceuticals In